Comment
June 2019

Families USA files amicus in Columbus et al. v. Trump ("Take Care") case

Families USA files amicus in Columbus et al. v. Trump (“Take Care”) case

A coalition of cities (Columbus, Baltimore, Cincinnati, Chicago, and Philadelphia) and two individuals filed a lawsuit challenging the Trump Administrations' many rules and administrative actions that sabotage the Affordable Care Act. The suit alleges that President Trump’s actions violate the President’s constitutional duty to “take care that the laws [of the United States] be faithfully executed.”

Comment
May 2019

Frederick Isasi's Testimony on High Drug Prices to the House Energy and Commerce Committee

In this testimony before the U.S. House of Representatives Energy and Commerce Committee on May 21, 2019, Frederick Isasi, Executive Director of Families USA, breaks down the problem with high drug prices and potential solutions under consideration by the committee. While high drug prices are a source of seemingly constant debate in Washington, D.C., for millions of America’s families, they are a painful and burdensome reality and can impact the basic necessities of life.

Comment
May 2019

Families USA Comments on Health Care Choice Compacts RFI

Families USA submitted comments on the Centers for Medicare and Medicaid Services Request for Information (RFI) concerning Health Care Choice Compacts. This RFI seeks to “facilitate the purchase of health insurance coverage across state lines.” We have long expressed concerns about policies that are designed to allow the sale of coverage across state lines if these policies do not include robust consumer protections.

Comment
May 2019

Families USA Comments on BHP Funding Methodology

The Centers for Medicare and Medicaid Services (CMS) recently proposed significant cutbacks to federal funding for states implementing the ACA’s Basic Health Program (BHP) option. Minnesota and New York have used this option to provide their residents with substantially more affordable coverage. Under BHP, a state can provide residents up to 200 percent of the federal poverty level (FPL) with insurance that has lower deductibles and premiums than would be charged for private insurance in a health insurance marketplace.

Comment
April 2019

Families USA Comments on Safe Harbor Rule

Families USA submitted this comment to Secretary Azar on the proposed safe harbor rule changes. Under the proposed rule, discounts awarded by prescription drug manufacturers to plan sponsors under Medicare Part D and Medicaid managed care organizations or their contracted Pharmacy benefits managers (PBMs) would no longer be eligible for safe harbor under the Federal anti-kickback provisions of the Social Security Act.

Comment
February 2019

Families USA’s Comments on Proposed Rule on Medicare Part D Protected Classes

Late last year, the Trump administration released a proposed rule as part of its efforts to lower prescription drug prices that, if finalized, could have a significant impact on Medicare beneficiaries’ ability to access certain drugs under Medicare Part D. Medicare Part D, which covers prescriptions drugs beneficiaries pick up at pharmacies, is administered by private Part D plans. Much like commercial health insurance plans, these Part D plans use formularies to establish which drugs are covered and at what level of beneficiary-cost sharing.

Pages

Subscribe to Comment